Skip to content Skip to search
Solving Kids’ Cancer UK Children we help Donate
Powered by Google Translate

Google Translate uses Large Language Models (AI) to translate our content, therefore it may provide incorrect information when translated. Please check with your medical team before acting on any translated information.

A PowerPoint master slide with a map of the world above the word ‘TITAN’ , below are the logos of all the funding organisations.
2 December 2020 1 min read
Research update- December 2020

We are delighted to have announced the first International Neuroblastoma Research Initiative award to be funded under our AMRC-accredited research funding process, which will see a targeted drug introduced to frontline treatment for children with the hope
A scientist, wearing lab goggles, gloves and coat, looks down a white microscope. Another scientist is doing the same, in an out of focus background.
8 September 2020 1 min read
Research update - September 2020

This Autumn we are extremely busy with our ongoing International Neuroblastoma Research Initiatives.
A scientist in a lab coat and safety goggles operates advanced lab equipment, holding a tray of vials, in a well-equipped research laboratory.
21 July 2020 1 min read
Research update- July 2020

The impact of COVID-19 has been serious and will have long-lasting consequences for medical research in the UK, not least because so much of our medical research is funded by charities.
A close-up black-and-white image of medical infusion pumps administering treatment, with labels visible, indicating precise infusion rates.
28 April 2020 1 min read
Research update - May 2020

The coronavirus pandemic has brought new challenges to our ongoing research programme, as we work with experts worldwide to bring more, better and less toxic treatment to children in the UK and beyond.
A close-up of a person's hands holding a printed document in one hand and a pen in the other, at a desk with an open laptop in the background.
1 November 2019 4 min read
Outcome for children in the UK after high-risk neuroblastoma treatment

We explain the recent statement from the UK clinical community.
1 2 3 4